OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells
Joel Basken, Scott A. Stuart, Andrew J. Kavran, et al.
Molecular & Cellular Proteomics (2017) Vol. 17, Iss. 4, pp. 550-564
Open Access | Times Cited: 32
Joel Basken, Scott A. Stuart, Andrew J. Kavran, et al.
Molecular & Cellular Proteomics (2017) Vol. 17, Iss. 4, pp. 550-564
Open Access | Times Cited: 32
Showing 26-50 of 32 citing articles:
Identification of the Host Substratome of Leishmania-Secreted Casein Kinase 1 Using a SILAC-Based Quantitative Mass Spectrometry Assay
Despina Smirlis, Florent Dingli, Valentin Sabatet, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 5
Despina Smirlis, Florent Dingli, Valentin Sabatet, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 5
Cerebral organoid proteomics reveals signatures of dysregulated cortical development associated with human trisomy 21
Tristan McClure‐Begley, Christopher C. Ebmeier, Kerri E. Ball, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 6
Tristan McClure‐Begley, Christopher C. Ebmeier, Kerri E. Ball, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 6
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro
Xi‐Feng Jin, Gerald Spöttl, Julian Maurer, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1485-1485
Open Access | Times Cited: 5
Xi‐Feng Jin, Gerald Spöttl, Julian Maurer, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1485-1485
Open Access | Times Cited: 5
Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2
Laurel M. Pegram, Jennifer Liddle, Yao Xiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
Laurel M. Pegram, Jennifer Liddle, Yao Xiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1
In vitro Kinase-to-Phosphosite database (iKiP-DB) predicts kinase activity in phosphoproteomic datasets
Tommaso Mari, Kirstin Mösbauer, Emanuel Wyler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Tommaso Mari, Kirstin Mösbauer, Emanuel Wyler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
SILAKin: A novel high throughput SILAC and mass spectrometry-based assay to identify the substratome of kinases secreted by pathogens
Despina Smirlis, Florent Dingli, Valentin Sabatet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Despina Smirlis, Florent Dingli, Valentin Sabatet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
